Creation of the second ABL entity in France through the acquisition of the Accinov innovative platform in Lyon
Category: history
2016
Creation of the first ABL entity in France through the acquisition of the Transgene production asset in Strasbourg* * Expansion of ABL capabilities through the viral vector manufacturing plant, certified GMP in 1995.
2014
ABL acquires Platine Pharma in Lyon and built GCLP testing labs
2011
ABL opens Rockville, MD headquarters
2004
ABL spun out from bioMérieux as a sister company, under Institut Mérieux
2001
ABL acquired by bioMérieux. ABL becomes an Institut Mérieux Company
1985
Organon Teknika acquires R&D and diagnostic assets, renames company ABL
1968
Acquired by Litton Industries. Expanded activities in retrovirus and cancer research
1961
Bionetics Research Laboratory was established